Drug Profile
Research programme: universal influenza vaccine - FluGen
Alternative Names: H5N1 viral vaccine - FluGenLatest Information Update: 28 Mar 2023
Price :
$50
*
At a glance
- Originator FluGen
- Class Influenza A vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Influenza A virus infections
Most Recent Events
- 28 Mar 2023 Universal influenza vaccine is still in preclinical trials for Influenza-A-virus-infections in USA
- 28 Feb 2020 No recent reports of development identified for preclinical development in Influenza-A-virus-infections in USA (Intranasal, Spray)
- 14 Feb 2018 Preclinical development is ongoing in USA